ESR1 and cancer: In the MPA/DMBA-induced mouse mode of HR+ BC, genetically-induced estrogen receptor deficiency leads to a delay in cancer development, and this effect could be phenocopied by continuous treatment with the estrogen receptor antagonist tamoxifen.